CABA

NASDAQ · Biotechnology

Cabaletta Bio Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.35

+0.08 (+2.45%)

CABA News1 articles

Cabaletta Bio Surges 32% on Early Cell Therapy Data and $150M Financing

Cabaletta Bio shares surged 32% on early cell therapy data and a $150M stock offering. Two of four patients showed clinical activity with rese-cel.